Kulicke & Soffa Industries, a leader in semiconductor assembly technology, will release its Q4 2026 financial results on November 18, 2026, followed by a conference call on November 19 to discuss the quarter's performance and business outlook. Investors can access the call via phone or webcast, with a replay available until November 26. This update is important for stakeholders tracking the company's progress in key tech markets like AI, automotive, and communications.
Kulicke & Soffa's upcoming Q4 2026 conference call provides context for readers following semiconductor-related updates. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 10, 2026 20:03 WIB: Out of 150 priced Technology-sector US stocks, 40 rose and 101 fell today. Among notable movers, GRAB traded at USD 3.23 with a 1-day change of -6.10% and a typical hold time of 96 days, contrasting with QUBT at USD 6.45 down 5.98% and held for 30 days, while IONQ stood at USD 33.30 with a -5.77% change and a 39-day hold time. Pluang order activity showed predominantly sell orders for GRAB and QUBT, but a higher buy interest for IONQ.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
